New survival data for pembrolizumab plus axitinib in advanced kidney cancer
A paper published in The Lancet Oncology this month provides [...]
A paper published in The Lancet Oncology this month provides [...]
In this phase 1b/2 study the researchers looked at a [...]
The COSMIC-021 clinical trial investigated a combination of cabozantinib and [...]
In this video interview with Dr Monty Pal from the [...]
The discovery of a reliable biomarker for metastatic renal cell [...]
The Sottish Medicine Consortium (SMC) have issued a final decision to recommend [...]
In this study, 6,043 patients with metastatic renal cell carcinoma [...]
Cabozantinib and sunitinib are both drugs that block the development [...]
Most studies have shown that many cancer patients are at [...]
In this video interview, Dr Jeffrey Kirshner from the Haematology-Oncology Associates [...]